Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Renal toxicity in man treated with mitomycin C
1971 • 116 citations
Renal disease after mitomycin c therapy
1981 • 115 citations
Pharmacology of mitomycin C. I. Toxicity and pathologic effects.
1960 • 104 citations
Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma
1981 • 89 citations
Sustained-release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog
1980 • 86 citations
Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C
1979 • 86 citations
Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil
1980 • 76 citations
INTRAVASCULAR HÆMOLYSIS AND RENAL IMPAIRMENT AFTER BLOOD TRANSFUSION IN TWO PATIENTS ON LONG-TERM 5-FLUOROURACIL AND MITOMYCIN-C
1980 • 68 citations
Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
1975 • 68 citations
Hemolytic-uremic syndrome associated with mitomycin therapy.
1982 • 50 citations
Mitomycin-Associated Renal Failure
1983 • 47 citations
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
1983 • 45 citations
Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.
1982 • 44 citations
The mesangial cell in glomerulonephritis. II. Mesangial proliferation caused by Habu snake venom in the rat.
1977 • 40 citations
Chronic glomerular microangiopathy and metastatic carcinoma
1979 • 37 citations
Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
1983 • 34 citations